Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with L
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q3 2024 | LACTIC ACID | AURICULAR (OTIC) | SOLUTION/ DROPS | ADJ PH | Deletion | ||
| Q2 2024 | LACTIC ACID, L- | INTRAVENOUS | INJECTION | 0.40 %w/v | MDE Replacement | ||
| Q3 2024 | LACTIC ACID, L- | INTRAVENOUS | INJECTION | 51mg | MDE Replacement | ||
| Q2 2024 | LACTIC ACID, L- | SUBCUTANEOUS | INJECTION | 0.30 %w/v | MDE Replacement | ||
| Q3 2024 | LACTIC ACID, L- | SUBCUTANEOUS | INJECTION | 51mg | MDE Replacement | ||
| Q2 2024 | LACTOSE MONOHYDRATE | VAGINAL | CREAM | NA | MDE Replacement | ||
| Q3 2024 | LACTOSE MONOHYDRATE | VAGINAL | CREAM | 586mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 3, 2024
Database Last Updated: July 31, 2024